These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6093431)

  • 21. Testing and evaluation of opiate analgesics and antagonists.
    Hahn EF
    Methods Find Exp Clin Pharmacol; 1985 Jul; 7(7):373-81. PubMed ID: 2865415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that opiate receptors mediate suppression of hypertonic saline-induced drinking in the mouse by narcotic antagonists.
    Brown DR; Holtzman SG
    Life Sci; 1980 May; 26(18):1543-50. PubMed ID: 6248713
    [No Abstract]   [Full Text] [Related]  

  • 23. Opiate receptor revisited.
    Snyder SH
    Anesthesiology; 2007 Oct; 107(4):659-61. PubMed ID: 17893463
    [No Abstract]   [Full Text] [Related]  

  • 24. Does interferon exert its actions through opiate receptors.
    Reyes-Vazquez C; Weisbrodt N; Dafny N
    Life Sci; 1984 Aug; 35(9):1015-21. PubMed ID: 6088931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1beta responses using c-fos expression in the rat brain.
    Buller KM; Hamlin AS; Osborne PB
    Neuropharmacology; 2005 Aug; 49(2):230-42. PubMed ID: 15993445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral endorphin: can in vitro experiments explain in vivo results?
    Sarne Y; Gothilf Y; Weissman BA
    Prog Biochem Pharmacol; 1980; 16():41-8. PubMed ID: 6255489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The binding and analgesic properties of a sigma opiate, SKF 10,047.
    Pasternak GW; Carroll-Buatti M; Spiegel K
    J Pharmacol Exp Ther; 1981 Oct; 219(1):192-8. PubMed ID: 6270299
    [No Abstract]   [Full Text] [Related]  

  • 28. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties.
    Magnan J; Paterson SJ; Tavani A; Kosterlitz HW
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jun; 319(3):197-205. PubMed ID: 6125900
    [No Abstract]   [Full Text] [Related]  

  • 29. Current status of preclinical research on disposition, pharmacokinetics, and metabolism of naltrexone.
    Misra AL
    NIDA Res Monogr; 1981; 28():132-46. PubMed ID: 6267469
    [No Abstract]   [Full Text] [Related]  

  • 30. Some aspects of opiate receptors.
    Herz A; Schulz R; Wüster M
    Adv Biochem Psychopharmacol; 1980; 21():329-37. PubMed ID: 6246748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid receptors and their subtypes: focus on peripheral isolated tissue preparations.
    Traynor JR
    Neurochem Int; 1994 May; 24(5):427-32. PubMed ID: 7647697
    [No Abstract]   [Full Text] [Related]  

  • 32. Fluorescent probes for opioid receptors.
    Kolb VM; Koman A; Terenius L
    Life Sci; 1983; 33 Suppl 1():423-6. PubMed ID: 6319896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opiate receptors in the brain.
    Snyder SH
    N Engl J Med; 1977 Feb; 296(5):266-71. PubMed ID: 12470
    [No Abstract]   [Full Text] [Related]  

  • 34. The possible role of protein phosphatase 2A in the sodium sensitivity of the receptor binding of opiate antagonists naloxone and naltrindole.
    Murányi A; Gergely P; Nagy GM; Fekete MI
    Brain Res Bull; 1997; 44(3):273-9. PubMed ID: 9323442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear [3H]naloxone binding in rat hypothalamus.
    Vértes Z; Környei JL; Kovács S; Vértes M
    Neuroreport; 1995 Nov; 6(17):2385-8. PubMed ID: 8747159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists.
    Pasternak GW; Wilson HA; Snyder SH
    Mol Pharmacol; 1975 May; 11(3):340-51. PubMed ID: 49846
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the opioid antagonist properties of a cyclic somatostatin analog in vitro and in vivo.
    Shook JE; Pelton JT; Kazmierski W; Lemcke PK; Wire WS; Hruby VJ; Burks TF
    NIDA Res Monogr; 1986; 75():205-8. PubMed ID: 2893263
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone.
    Iijima I; Minamikawa J; Jacobson AE; Brossi A; Rice KC
    J Med Chem; 1978 Apr; 21(4):398-400. PubMed ID: 206698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone-6 alpha-spirohydantoin: a long-acting opiate antagonist.
    Alexander GJ; Chatterjie N
    Neurochem Res; 1989 Dec; 14(12):1229-34. PubMed ID: 2560821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guanine nucleotides differentiate agonist and antagonist interactions with opiate receptors.
    Childers SR; Snyder SH
    Life Sci; 1978 Aug; 23(7):759-61. PubMed ID: 211364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.